NCT04042428View on ClinicalTrials.gov

Generation of Biological Samples Positive to Somatropin for Anti-doping Control

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

October 25, 2019

Primary Completion Date

January 8, 2020

Study Completion Date

January 8, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

Somatropin injection

Subjects receive a daily subcutaneous dose of 0.2 IU/kg (0.067 mg/kg) of recombinant somatropin (rhGH) during 14 days.

Trial Locations (1)

08003

IMIM (Hospital del Mar Medical Research Institute), Barcelona

All Listed Sponsors
lead

Parc de Salut Mar

OTHER

NCT04042428 - Generation of Biological Samples Positive to Somatropin for Anti-doping Control | Biotech Hunter | Biotech Hunter